SH3KBP1 Antibody

說明書

中文名稱：

SH3KBP1兔多克隆抗體
貨號：

CSB-PA546597
規格：

￥1100
圖片：
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA546597(SH3KBP1 Antibody) at dilution 1/45, on the right is treated with fusion protein. (Original magnification: ×200)

The image on the left is immunohistochemistry of paraffin-embedded Human breast cancer tissue using CSB-PA546597(SH3KBP1 Antibody) at dilution 1/45, on the right is treated with fusion protein. (Original magnification: ×200)

Gel: 8%SDS-PAGE,Lysate: 40 μg,,Primary antibody: CSB-PA546597(SH3KBP1 Antibody) at dilution 1/800 dilution,Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution,Exposure time: 30 seconds
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

Q96B97
基因名：

SH3KBP1
別名：

c Cbl interacting protein antibody; Cbl interacting protein antibody; Cbl interacting protein of 85 kDa antibody; Cbl-interacting protein of 85 kDa antibody; CD2 binding protein 3 antibody; CD2-binding protein 3 antibody; CD2BP3 antibody; CIN 85 antibody; CIN85 antibody; GIG 10 antibody; GIG10 antibody; HSB 1 antibody; HSB-1 antibody; HSB1 antibody; Human Src family kinase binding protein 1 antibody; Human Src family kinase-binding protein 1 antibody; MIG 18 antibody; MIG18 antibody; Migration inducing gene 18 antibody; Migration inducing gene 18 protein antibody; SH3 domain kinase binding protein 1 antibody; SH3 domain-containing kinase-binding protein 1 antibody; SH3BP 1 antibody; SH3K1_HUMAN antibody; SH3KBP1 antibody; Src family kinase binding protein 1 antibody; src related kinase binding protein 1 antibody
宿主：

Rabbit
反應種屬：

Human,Mouse,Rat
免疫原：

Fusion protein of Human SH3KBP1
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

Antigen affinity purification
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
產品提供形式：

Liquid
應用范圍：

ELISA,WB,IHC

推薦稀釋比：

Application	Recommended Dilution
ELISA	1:2000-1:5000
WB	1:500-1:2000
IHC	1:30-1:150

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Adapter protein involved in regulating diverse signal transduction pathways. Involved in the regulation of endocytosis and lysosomal degradation of ligand-induced receptor tyrosine kinases, including EGFR and MET/hepatocyte growth factor receptor, through an association with CBL and endophilins. The association with CBL, and thus the receptor internalization, may be inhibited by an interaction with PDCD6IP and/or SPRY2. Involved in regulation of ligand-dependent endocytosis of the IgE receptor. Attenuates phosphatidylinositol 3-kinase activity by interaction with its regulatory subunit. May be involved in regulation of cell adhesion; promotes the interaction between TTK2B and PDCD6IP. May be involved in the regulation of cellular stress response via the MAPK pathways through its interaction with MAP3K4. Is involved in modulation of tumor necrosis factor mediated apoptosis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Has an essential role in the stimulation of B cell activation.
基因功能參考文獻：
1. The multiple Src homology 3 (SH3) domains of trimeric CIN85 molecules associated with multiple SLP-65 molecules, which recruited further CIN85 trimers, thereby perpetuating the oligomerization process. PMID: 27353366
2. these data support a role for the novel PP2Ac-CIN85 complex in supporting integrin-dependent platelet function by dampening the phosphatase activity. PMID: 27334924
3. CIN85 promotes recycling of TGF-beta receptors and thereby positively regulates TGF-beta signaling. PMID: 26169354
4. Results support the model that Cbl-CIN85-endophilin complex is not required for efficient internalization of EGFR, a prototype RTK. PMID: 25449262
5. Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma cell line. PMID: 25816594
6. LOX-PP interacts with CIN85 via a novel SH3-binding motif and this association reduces CIN85-promoted invasion by breast cancer cells. PMID: 24167568
7. Data show that EGFR activation leads to a pronounced src-mediated tyrosine phosphorylation of CIN85 that subsequently influences EGFR ubiquitination. PMID: 22833562
8. this study indicates that high levels of Ruk(l)/CIN85 contribute to the conversion of breast adenocarcinoma cells into a more malignant phenotype via modulation of the Src/Akt pathway. PMID: 22791810
9. Data show that CIN85 (c-Cbl interacting protein of 85 kDa) is constitutively associated with c-Cbl, Cbl-b, and B-cell linker in B cells. PMID: 22262777
10. The CIN85 was constitutively associated with Hrs, and this strengthens the hypothesis of a functional role of CIN85 in endosomal EGFR sorting. PMID: 21635887
11. the ubiquitination and degradation of stimulated FcgammaRIIa mediated by c-Cbl are positively regulated by the adaptor protein CIN85 in a PKC-dependent manner and these events contribute to the termination of FcgammaRIIa signaling. PMID: 21372129
12. the N- and C-termini are important for the structure, stability, and function of the third SH3 domain of CIN85 PMID: 21446695
13. ARAP1 associated with CIN85 affects epidermal growth factor receptor endocytic trafficking. PMID: 21275903
14. High CIN85 is associated with the development and progression of head and neck squamous cell carcinoma. PMID: 20927317
15. CIN85 binding to a C-terminal motif within hTTP leads to the increased phosphorylation of hTTP, possibly through enhanced association with MEKK4 PMID: 20221403
16. Ruk/CIN85 induces PAI-1 expression via modulation of HIF-1alpha stability PMID: 20216986
17. The ORF3 protein of hepatitis E virus was found to interact with CIN85 and compete with the formation of the growth factor receptor-Cbl-CIN85 complex, resulting in the reduced ubiquitination of CIN85. PMID: 20130058
18. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors PMID: 11894095
19. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met PMID: 11894096
20. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases PMID: 12177062
21. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. PMID: 12218189
22. Cd2 antigen is linked to CAPZ via this protein and CMS. PMID: 12690097
23. forms complexes with endonucleases in HEK293 cells PMID: 12946264
24. CIN85 association with Dab2 is essential for its recruitment to clathrin coat and appears to be modulated by growth factor stimulation PMID: 14596919
25. Data show that infected cell protein 0 (ICP0) binds CIN85 in a reciprocal manner and that the complexes pulled down by ICP0 also contain Cbl. PMID: 15824310
26. CIN85 might play an important role in HSV-1 infection. PMID: 16223483
27. Taken together, these results indicate a novel role for CIN85 in the regulation of cellular stress response via the MAPK pathways. PMID: 16256071
28. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. PMID: 17255943
29. a new role for CIN85 in regulating Syk protein levels in RBL-2H3 cells through the activation of the ubiquitin-proteasome pathway and provide a mechanism for this regulation involving c-Cbl ligase activity. PMID: 17675467
30. These results suggest that endogenous Ruk/CIN85 may be involved in regulation of specific membrane trafficking processes. PMID: 18266907
31. Results suggest that competition between Cbl and ubiquitin binding to CIN85 regulates Cbl function and EGFR endocytosis. PMID: 18680311
32. Epidermal Growth Factor stimulation increases association of Cbl and Ruk/CIN85, which is dependent on tyrosine phosphorylation of the C-terminal region of Proto-Oncogene Proteins Cbl. PMID: 19166927
33. detailed high-resolution solution structural study of CIN85A and CIN85B binding to proline-arginine peptides derived from the cognate ligands Cbl and Cbl-b PMID: 19268472
34. CIN85 (SH3-domain kinase binding protein 1) associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis. PMID: 15707590
顯示更多

收起更多
亞細胞定位：

Cytoplasm. Cytoplasm, cytoskeleton. Cytoplasmic vesicle membrane; Peripheral membrane protein. Cell junction, synapse, synaptosome. Cell junction, focal adhesion.
組織特異性：

Ubiquitously expressed. Also expressed in some cancer cell lines.
數據庫鏈接：

HGNC: 13867

OMIM: 300374

KEGG: hsa:30011

STRING: 9606.ENSP00000380921

UniGene: Hs.726365

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human